Carotid Risk Prediction (CRISP) Consortium

Status unconfirmed

Conditions studied: Carotid Atherosclerosis

In brief

Develop adverse event prediction and plaque phenotype classification models for patients with known or suspected carotid artery disease.

Key facts

Study ID

NCT04448353

Run by

Elucid Bioimaging Inc.

People needed

800

Starts

2019-03-01

Expected to finish

2022-04-30

Last updated by the study team

2021-02-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects must have two (or more) neck CTAs at least 6 months apart of sufficient quality as documented in the vascuCAP Reading Manual.
• Atherosclerotic plaque must be visualized within the carotid artery.

You may not qualify if…

• Subjects without visible plaque within the carotid artery
• Subject with insufficient CTA image quality (defined strictly as documented in the vascuCAP Reading Manual)

Where it is running

• Baltimore VA Medical Center — Baltimore, Maryland, United States (enrolling)
• University of Maryland, Baltimore — Baltimore, Maryland, United States (enrolling)
• Walter Reed National Military Medical Center — Bethesda, Maryland, United States (enrolling)
• Weill Cornell Medicine (Affiliated with New York Presbyterian Hospital) — New York, New York, United States (enrolling)
• University Hospital Harrington (Affiliated with Case Western Reserve University) — Cleveland, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.